The effect of statin on the met-enkephalin-like peptides in the diabetic piglets striatum

• Autorzy: Pierzchala-Koziec K. , Zubel J. , Oclon E. , Fedorczak J.
• Języki publikacji: EN

Abstrakty

EN

• Wydawca: -
• Czasopismo: Acta Biologica Cracoviensia. Series Zoologia
• Rocznik: 2010
• Tom: 52
• Opis fizyczny: p.19-23,fig.,ref.

Twórcy

autor

Pierzchala-Koziec K.

• Department of Animal Physiology and Endocrinology, University of Agriculture, Al.Mickiewicza 24/ 28, Cracow, Poland

autor

Zubel J.

• Department of Animal Physiology and Endocrinology, University of Agriculture, Al.Mickiewicza 24/ 28, Cracow, Poland

autor

Oclon E.

• Department of Animal Physiology and Endocrinology, University of Agriculture, Al.Mickiewicza 24/ 28, Cracow, Poland

autor

Fedorczak J.

• Department of Animal Physiology and Endocrinology, University of Agriculture, Al.Mickiewicza 24/ 28, Cracow, Poland

Bibliografia

• CHESSELET, M.F., L. WEISS, C. WUENSCHELL, A.J. TOBIN, and H.U. AFFOLTER. 1987. Comparative distribution of mRNAs glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: An in situ hybridization study in the rodent brain. J. Comp. Neurol. 262: 125-140.
• CHESSELET, M.F. 1999. Mapping the basal ganglia. In A.W. Toga and J.C. Maziotta. Eds. Brain Mapping: The Application. Acad. Press, 141-149.
• DIXON J.L., S. SHEN, J.P. VUCHETICH, E. WYSOCKA, G.Y. SUN, and M. STUREK. 2002. Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotin profile. J. Lipid Res. 43: 1618-1629.
• EGLEN R.M. 2005. Muscarinic receptor subtype pharmacology and physiology. Prog. Med. Chem. 43: 105-136.
• GERRITY R.G., R. NATARAJAN, J.L. NADLER, and T. KIMSEY. 2001. Diabetes-induced accelerated atherosclerosis in swine. Diabetes, 50: 1654—1665.
• GIREESH, G., T.P. KUMAR, M. JOBIN, and C.S. PAULOSE. 2009. Enhanced muscarinic Ml receptor gene expression in the corpus striatum of streptozotocin-induced diabetic rats. J. Biomed. Sci. 16: 16-38.
• KARALIS, D.G., A.M. Ross, R.M. VACARI, H. ZARREN, and R. SCOTT. 2002. Comparison of efficiency and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease. Am. J. Cardiol. 89: 667- -671.
• KOH, K.K. 2000. Effects of statins on vascular walhvasomotor function, inflammation, and plaque stability. Cardiovasc. Res. 47: 648-657.
• KOLTA, M.G., J.M. NGONG, L.P. RUTLEDGE, K. PIERZCHALA, and G.R. VAN LOON. 1996. Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats. Neuropeptides. 30: 335-344.
• KOLTA, M.G., K. PIERCHALA, A.A. HOUDI, and G.R. VAN LOON. 1992. Effect of diabetes on the levels of two forms of Met- enkephalin in plasma and peripheral tissues of the rat. Neuropeptides. 21: 55-63.
• Lusis, A.J. 2000.Atherosclerosis. Nature. 407: 233-241.
• MENALLED L., H. ZANJANI, L. MACKENZIE, A. KOPPEL, E. CARPENTER, S. ZEITLIN, and M.F. CHESSELET. 2000. Decrease in striatal enkephalin mRNA in mouse models of Huntington’s disease. Exp. Neurol. 162: 328-342.
• PIERZCHALA, K. and G.R. VAN LOON. 1990. Plasma native and peptides-derivable Met-enkephalin responses to restraint stress in rats. Adaptation to repeated restraint. J. Clin. Invest. 85: 861-865.
• PIERZCHALA-KOZIEC, K. 2010. Stress modulation of ghrelin and opioids in brain of growing animals. Int. Congress Neuroendocrinol. Rouen, July 11-15, s. 77-1.
• RUDERMAN, N.N. and G.S. SUSSMAN. 1992. Hyperglycemia, diabetes, and vascular disease: an overwiew. In Hyperglycemia, Diabetes and Vascular Disease. Eds. New York, Oxford Univ. Press, 3-20.

Uwagi

PL

Rekord w opracowaniu